Understanding how a protein affects B cell development and lymphoma

Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis

NIH-funded research Rockefeller University · NIH-10817664

This study is looking at a protein called OCA-B to see how it helps B cells, which are important for our immune system, grow and work properly, and it could also help us understand how some blood cancers, like Burkitt's lymphoma, develop.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRockefeller University NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10817664 on NIH RePORTER

What this research studies

This research investigates the role of a protein called OCA-B in the development of B cells, which are crucial for a healthy immune system. It focuses on how OCA-B influences the formation of germinal centers, where B cells mature and produce antibodies. By studying the mechanisms behind OCA-B's function, researchers aim to uncover its impact on both normal immune responses and the progression of certain lymphomas, such as Burkitt's lymphoma. The approach includes in vivo studies to observe OCA-B's interactions and effects on gene regulation in B cells.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals with autoimmune disorders or those diagnosed with B cell lymphomas.

Not a fit: Patients with non-B cell related cancers or those without autoimmune conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for autoimmune diseases and lymphomas, improving patient outcomes.

How similar studies have performed: Previous research has shown promising results in understanding the roles of transcriptional coactivators in immune cell development, suggesting potential for success in this area.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions autoimmune disorderautoimmunity diseaseAutoimmune Diseases
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.